Skip to main content
IOSPInnospec Inc.Sell5.7·$83.74-1.61%
Open full analysis

Innospec Inc. (IOSP) Stock Analysis

Breakout setup

SellVALUE-TRAP 1/5Moderate Confidence

Basic Materials · Specialty Chemicals

Sell if holding. Analyst target reached at $83.74 — A.R:R 0.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: ethylene single source (German operations) (4.0%).

Innospec develops, manufactures, and supplies specialty chemicals through three segments — Performance Chemicals, Fuel Specialties, and Oilfield Services — serving customers in the Americas, Europe, Middle East, Africa, and Asia-Pacific with approximately 2,450 employees in 22... Read more

$83.74+0.8% A.UpsideScore 5.7/10#11 of 36 Specialty Chemicals
QualityF-score7 / 9FCF yield0.57%
IncomeYield2.10%(5y avg 1.46%)Payout37.34%sustainable
Stop $79.74Target $84.43(analyst − 15%)A.R:R 0.1:1
Analyst target$99.33+18.6%3 analysts
$84.43our TP
$83.74price
$99.33mean
$105

Sell if holding. Analyst target reached at $83.74 — A.R:R 0.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: ethylene single source (German operations) (4.0%). Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Score 5.7/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 49d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About Innospec Inc.

About Innospec Inc.

Innospec operates three specialty chemicals segments — Performance Chemicals, Fuel Specialties, and Oilfield Services — selling to customers across the Americas, Europe, the Middle East, Africa, and Asia-Pacific from approximately 2,450 employees in 22 countries. R&D expenditures of $51.0 million in 2025, $56.5 million in 2024, and $49.0 million in 2023 support new formulations including mild surfactants in Performance Chemicals, emission-reducing detergents in Fuel Specialties, and friction modifiers and biocide formulations in Oilfield Services.

Innospec earns revenue by selling specialty chemical products to national and multinational oil companies, fuel marketers, fuel terminals, marine lines, large personal care and home care manufacturers, and exploration & production companies operating principally in the Americas and the Middle East. Key raw material purchases — oleochemicals, cetane number improvers, ethylene, solvents, amines, alcohols, and polyacrylamides — represent a substantial portion of variable manufacturing costs; most are available from multiple sources, but ethylene for one German facility arrives via a dedicated pipeline that functions as a single source, supplying products representing approximately 4% of group sales. Within Fuel Specialties, the company holds the sole position as producer of tetraethyl lead for aviation gasoline, marketed as the AvGas product line. Oilfield Services margins are sensitive to oil and gas exploration and production activity, which is subject to commodity price trends.

Show full overview

The AvGas product line faces a dated regulatory transition: a U.S. industry coalition (EAGLE) has stated an aim to eliminate lead emissions from general aviation by the end of 2030, with an Alaskan derogation extending to the end of 2032. In the EU, three users obtained REACH Authorization permitting continued use of TEL until the end of April 2032. If a suitable unleaded replacement is identified and lead prohibition is implemented, Innospec's future operating income and cash flows from the AvGas line could be adversely impacted — though the 10-K notes no currently available alternative exists.

See also: Basic Materials · Specialty Chemicals

From Innospec Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202649d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Risks
Concentration risk — Supplier: ethylene single source (German operations) (4.0%)
Analyst target reached - limited upside remaining
Leverage penalty (D/E 3.7): -1.5

Key Metrics

P/E (TTM)18.6
P/E (Fwd)13.9
Mkt Cap$2.1B
EV/EBITDA10.0
Profit Mgn6.4%
ROE8.7%
Rev Growth2.8%
Beta0.91
Dividend2.10%
Rating analysts9

Quality Signals

Piotroski F7/9

Options Flow

P/C1.21bearish
IV38%normal
Max Pain$55-34.3% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHSupplierethylene single source (German operations)4.0%
    10-K Item 1: 'we source ethylene for our German operations via a direct pipeline, making it effectively a single source ... products representing approximately 4% of Innospec's sales'

Material Events(8-K, last 90d)

  • 2026-06-04Item 5.02LOW
    Board expanded from 7 to 8 directors; Shelley Bausch appointed Class II director effective July 1, 2026, also to serve on Audit Committee. Standard non-employee director compensation. No reason cited beyond board expansion.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesA.R:R 0.1 < 1.5@spotExecutive change: officer departure/appointmentMomentum 5.6>=5.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 49d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
56 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $76.16Resistance $87.82

Price Targets

$80
$84
A.Upside+0.8%
A.R:R0.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (0.8% upside)
! asymmetry at 0.1 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-04 (49d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is IOSP stock a buy right now?

Sell if holding. Analyst target reached at $83.74 — A.R:R 0.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: ethylene single source (German operations) (4.0%). Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Prior stop was $79.74. Score 5.7/10, moderate confidence.

What is the IOSP stock price target?

Take-profit target: $84.43 (+0.8% upside). Prior stop was $79.74. Stop-loss: $79.74.

What are the risks of investing in IOSP?

Concentration risk — Supplier: ethylene single source (German operations) (4.0%); Analyst target reached - limited upside remaining; Leverage penalty (D/E 3.7): -1.5.

Is IOSP overvalued or undervalued?

Innospec Inc. trades at a P/E of 18.6 (forward 13.9). TrendMatrix value score: 7.7/10. Verdict: Sell.

What do analysts say about IOSP?

9 analysts cover IOSP with a consensus score of 4.1/5. Average price target: $99.

What does Innospec Inc. do?Innospec develops, manufactures, and supplies specialty chemicals through three segments — Performance Chemicals, Fuel...

Innospec develops, manufactures, and supplies specialty chemicals through three segments — Performance Chemicals, Fuel Specialties, and Oilfield Services — serving customers in the Americas, Europe, Middle East, Africa, and Asia-Pacific with approximately 2,450 employees in 22 countries. Revenue comes from fuel additives, personal care ingredients, and oilfield drilling chemicals sold to multinational oil companies, personal care manufacturers, and exploration & production companies.

Related stocks: MTX (Minerals Technologies Inc.) · ECVT (Ecovyst Inc.) · ALB (Albemarle Corporation) · ESI (Element Solutions Inc.) · KWR (Quaker Houghton)
Home Stocks IOSP

Latest news

Latest News

TradingView35d ago
AlphaStreet43d agoEarnings
Yahoo Finance48d agoEarnings
TradingView48d ago
Yahoo Finance41d ago
Moomoo41d agoEarnings
Stock Titan41d ago
Yahoo Finance40d ago
Seeking Alpha40d agoEarnings
MSN47d ago
Benzinga41d ago
Benzinga41d ago
Benzinga65d ago